Medical supply and logistics company Owens & Minor (NYSE:OMI) will be reporting earnings tomorrow before market hours. Here’s what to look for.

Owens & Minor met analysts’ revenue expectations last quarter, reporting revenues of $2.70 billion, up 1.5% year on year. It was a slower quarter for the company, with a significant miss of analysts’ full-year EPS guidance estimates.

Is Owens & Minor a buy or sell going into earnings? Read our full analysis here, it’s free.

This quarter, analysts are expecting Owens & Minor’s revenue to grow 2.4% year on year to $2.67 billion, slowing from the 3.6% increase it recorded in the same quarter last year. Adjusted earnings are expected to come in at $0.20 per share.Owens & Minor Total Revenue

Analysts covering the company have generally reconfirmed their estimates over the last 30 days, suggesting they anticipate the business to stay the course heading into earnings. Owens & Minor has missed Wall Street’s revenue estimates twice over the last two years.

Looking at Owens & Minor’s peers in the healthcare providers & services segment, some have already reported their Q1 results, giving us a hint as to what we can expect. Cardinal Health posted flat year-on-year revenue, missing analysts’ expectations by 1%, and Alignment Healthcare reported revenues up 47.5%, topping estimates by 4.4%. Cardinal Health traded up 5.9% following the results while Alignment Healthcare was down 7%.

Read our full analysis of Cardinal Health’s results here and Alignment Healthcare’s results here.

There has been positive sentiment among investors in the healthcare providers & services segment, with share prices up 5.9% on average over the last month. Owens & Minor is up 4.1% during the same time and is heading into earnings with an average analyst price target of $10.43 (compared to the current share price of $8.09).

Unless you’ve been living under a rock, it should be obvious by now that generative AI is going to have a huge impact on how large corporations do business. While Nvidia and AMD are trading close to all-time highs, we prefer a lesser-known (but still profitable) semiconductor stock benefiting from the rise of AI. Click here to access our free report on our favorite semiconductor growth story.

View Comments